Anika Therapeutics Inc
F:AKP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
M
|
Metso Outotec Corp
XBER:M6Q
|
FI |
|
Tubacex SA
MAD:TUB
|
ES |
|
T
|
Tesco PLC
BMV:TSCON
|
UK |
|
Amadeus IT Group SA
F:AI3A
|
ES |
|
G
|
Globe Life Inc
XBER:TMJ
|
US |
|
E
|
Equity Residential
F:EQR
|
US |
|
A
|
Autodesk Inc
SWB:AUD
|
US |
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
Unilever PLC
LSE:ULVR
|
UK |
|
Ypsomed Holding AG
F:OWX
|
CH |
|
M
|
Moody's Corp
DUS:DUT
|
US |
|
Bob's Discount Furniture, Inc
NYSE:BOBS
|
US |
|
Amadeus IT Group SA
MAD:AMS
|
ES |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
Logitech International SA
NASDAQ:LOGI
|
CH |
|
Americold Realty Trust
NYSE:COLD
|
US |
|
A
|
Autodesk Inc
DUS:AUD
|
US |
|
Applovin Corp
NASDAQ:APP
|
US |
|
Rolls-Royce Holdings PLC
LSE:RR
|
UK |
|
Barito Pacific Tbk PT
IDX:BRPT
|
ID |
Bankruptcy Probability
Anika Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Anika Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
205.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Anika Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Anika Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
